AGO2 and triple-negative breast carcinoma: From all the RBPs investigated, seven were differentially expressed and upregulated (AGO2, EIF4A3, ELAVL1, IGF2BP2/3, LIN28B, and U2AF2), showing that these genes have an important role in triple-negative breast cancer development.